Clinical Trials in Arizona

Showing 1681-1700 of 14,395 trials

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT03516617

This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating patients with early-stage chronic lymphocytic leukemia or small lymphocytic lymphoma. Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. It is not yet known whether giving acalabrutinib with or without obinutuzumab will work better in treating patients with early-stage chronic lymphocytic leukemia or small lymphocytic lymphoma.

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

Mayo Clinic120 participantsStarted Sep 2018

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States

RECRUITINGNA31 miles

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

NCT06055881

This study assesses if metastasis-directed radiation therapy (Stereotactic body radiation therapy - SBRT) can delay a change in systemic therapy, and if circulating tumor cells in the bloodstream can help guide treatment options in metastatic breast cancer patients with progressive disease

Breast CarcinomaAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Cancer

Mayo Clinic45 participantsStarted Oct 2023

Scottsdale, Arizona, United States • Rochester, Minnesota, United States

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

Find Trials by Condition in Arizona

Registry of the Patient Experience for Carpal Tunnel Release

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

FX Shoulder Prospective Clinical Study

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

His-Bundle Corrective Pacing in Heart Failure

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Factors in Learning And Plasticity: Healthy Vision

Intermuscular Coherence as a Biomarker for ALS

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI

PrEP Affect Regulation Treatment Innovation